UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 861177
NEW YORK, NY
Position in NBIX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$75,318,257
-$27,150,509 QoQ
Shares Held
571,719
-20.9% QoQ
Ownership
0.569%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 40.61785597470086.ToString("F0")%
Shared 0.ToString("F0")%
None 59.38214402529914.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $926,551,772 across 34 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,398,351 | $519,929,066 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
207,309 | $122,930,085 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
571,719 | $75,318,257 | |
| 4 | VTRS |
Viatris Inc
|
3,964,630 | $53,562,146 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
486,498 | $36,900,870 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
1,526,922 | $36,539,240 | |
| 7 | ALKS |
Alkermes plc.
|
403,153 | $14,255,486 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
443,527 | $9,207,616 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $75,318,257 | 571,719 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $102,468,766 | 722,476 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $107,423,964 | 765,237 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $174,411,836 | 1,387,635 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $128,225,984 | 1,159,367 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $146,068,100 | 1,070,096 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $103,031,676 | 894,217 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $125,563,845 | 912,064 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $82,672,554 | 599,424 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $81,355,603 | 617,453 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $66,295,234 | 589,291 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $53,645,190 | 568,878 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $57,581,826 | 568,878 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $64,809,572 | 542,612 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $54,594,695 | 514,026 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $48,568,236 | 498,238 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $48,334,495 | 515,568 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $29,841,007 | 350,370 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $26,310,985 | 274,330 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $24,988,267 | 256,764 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $41,353,225 | 425,226 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $64,311,991 | 670,965 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $54,634,647 | 568,164 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $65,972,842 | 540,761 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $41,447,061 | 478,880 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||